Published in J Am Acad Dermatol on May 01, 1993
"First do no harm" and the importance of prediction in oncology. EPMA J (2010) 0.86
Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo. BMC Complement Altern Med (2012) 0.77
I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab (1997) 1.10
In vitro synthesis of human IgE: reappraisal of a 5-year study. Int Arch Allergy Appl Immunol (1985) 1.01
Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice. Clin Exp Immunol (2008) 0.88
Anion gap in multiple myeloma. Acta Haematol (1979) 0.88
Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn. Cytokine (2005) 0.86
Lysozyme and cancer: role of exogenous lysozyme as anticancer agent (review). Anticancer Res (1989) 0.85
Monoclonal-oligoclonal immunoglobulins in HTLV III infected subjects: HTLV III-induced or HTLV III-associated? Boll Ist Sieroter Milan (1987) 0.83
Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma. Anticancer Res (1991) 0.81
[Treatment of human strongyloidiasis with a new antihelmintic, cambendazole. Double-blind study]. Rev Inst Med Trop Sao Paulo (1979) 0.81
An immunological evaluation of type II diabetic patients with periodontal disease. J Diabetes Complications (1999) 0.81
T-cell subsets in peripheral blood and ascitic fluid of patients with alcoholic liver cirrhosis. Lancet (1983) 0.80
Low frequency of autoantibodies to islet cell, glutamic acid decarboxylase, and second-islet antigen in patients with gestational diabetes mellitus: a follow-up study. Ann N Y Acad Sci (2002) 0.80
Inappropriate emergency test ordering in a general hospital: preliminary reports. Qual Assur Health Care (1992) 0.80
Preoperative chemoradiotherapy in cancer of the thoracic esophagus. Dis Esophagus (2003) 0.79
Evidence for host-mediated antitumor effects of lysozyme in mice bearing the MCa mammary carcinoma. Eur J Cancer Clin Oncol (1988) 0.78
Evaluation of T-cell receptor CD3+ gamma delta in gestational diabetes mellitus. Acta Diabetol (2000) 0.78
Benign Bence Jones gammopathy. Acta Haematol (1980) 0.78
Effect of high-dose steroid therapy on T-cell subpopulations. A longitudinal study in MS patients. Acta Neurol Scand (1994) 0.78
Effect of chemotherapy on the anion gap in multiple myeloma. Acta Haematol (1981) 0.77
Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study. Eur J Cancer (1994) 0.77
An immunological and genetic study of patients with gestational diabetes mellitus. Acta Diabetol (1996) 0.77
[Influence of radiotherapy on lymphocyte subpopulations]. Radiol Med (1991) 0.76
Dose finding of ifosfamide administered with a chronic two-week continuous infusion. Oncology (2003) 0.76
Mechanism of the antineoplastic action of lysozyme: evidence for host mediated effects. Anticancer Res (1989) 0.76
Antineoplastic effect of mer-trichlorobisdimethylsulphoxideaminorutheniumIII against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. Chem Biol Interact (1991) 0.75
Metal complexes of ruthenium: antineoplastic properties and perspectives. Anticancer Drugs (1990) 0.75
Metal complexes of ruthenium: a potential class of selective anticancer drugs. Anticancer Res (1991) 0.75
Intra-arterial Chemotherapy with Carboplatin (CBDCA) and Vepesid (VP16) in Primary Malignant Brain Tumours. Preliminary Findings. Interv Neuroradiol (2001) 0.75
[Correlations between the ergometric and follow-up parameters in 409 infarct patients]. Cardiologia (1983) 0.75
A study on lymphocyte subpopulations in diabetic pregnant women and their newborn. Ann Ist Super Sanita (1997) 0.75
[Behavior of hemostasis and coagulation during narcosis with methoxyflurane]. Rass Int Clin Ter (1965) 0.75
Treatment of taeniasis and hymenolepiasis nana with a single oral dose of praziquantel. Study of therapeutic efficacy, tolerance and safety. Mater Med Pol (1985) 0.75
IgD myeloma. A study of four cases. Haematologica (1986) 0.75
Increased content of CD34(+)CD38(-) hematopoietic stem cells in the last collected umbilical cord blood. Transplant Proc (2001) 0.75
[Correlation between ergometric parameters and follow-up in 409 infarct patients]. Cardiologia (1983) 0.75
Inhibition of carrageenin paw edema by pyridinalalkylimine rhodium(I) complexes. Anticancer Res (1989) 0.75
[Idiopathic monoclonal gammopathy. Long-term study of 313 cases]. Recenti Prog Med (1989) 0.75
Activated T cells in sarcoidosis. Am Rev Respir Dis (1979) 0.75
Effect of marrow processing on hematopoietic cell recovery in bone marrow harvests: focus on filtration. Bone Marrow Transplant (1995) 0.75
Effectiveness and toxicity of "BELD" polychemotherapy in advanced malignant melanoma. Tumori (1989) 0.75
[T lymphocyte subpopulations in rheumatoid arthritis]. Arch Sci Med (Torino) (1984) 0.75
B lymphocytes in sarcoidosis. Allergol Immunopathol (Madr) (1980) 0.75
[Properties of human lymphocytes binding to mouse red blood cells]. Boll Ist Sieroter Milan (1980) 0.75
A 99mTc-DTPA study on platinum chronic nephrotoxicity: also glomerular lesions? J Chemother (1989) 0.75
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis. Lung Cancer (2001) 0.75
Flow cytometric characterization of ex vivo expanded umbilical cord blood CD34(+) cells. Transplant Proc (2001) 0.75
Cancer chemotherapy does not enhance MDR-associated 170 kd glycoprotein expression in normal blood mononuclear cells. Haematologica (1993) 0.75
Monoclonal immunoglobulins in HTLV III-positive sera. Clin Chem (1986) 0.75
Cisplatin and gemcitabine in non-small-cell lung cancer. Ann Oncol (1999) 0.75
Immunity during monochemotherapy with mitoxantrone: preliminary results. J Chemother (1989) 0.75
[Multiple esophageal carcinomas and their association with primary carcinomas of other organs]. Pathologica (1982) 0.75
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patients. Cancer Biother Radiopharm (1996) 0.75
Identification with monoclonal antibodies of T-cell subsets in peripheral blood and ascitic fluid of patients with alcoholic hepatic cirrhosis. Boll Ist Sieroter Milan (1985) 0.75
[An unusual case of double IgD-IgA monoclonal gammopathy]. Pathologica (1982) 0.75
Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas. Am J Clin Oncol (1997) 0.75
Evaluation of the circulating glycoprotein CA549 in mammary cancer and other malignancies. Tumori (1991) 0.75
A phase II study of oral fluorouracil for gastrointestinal cancer. Anticancer Drugs (1996) 0.75
[Aneurysm of the splenic artery. Diagnosis with computerized tomography]. Minerva Chir (1995) 0.75
Evaluation of platelet function in postsplenectomy thrombocytosis. Folia Haematol Int Mag Klin Morphol Blutforsch (1987) 0.75
[Therapeutic of taeniasis and hymenolepiasis nana with single oral dose of praziquantel. Study of the efficacy, tolerance and safety]. Rev Inst Med Trop Sao Paulo (1981) 0.75
T-cell subsets in the differential diagnosis of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol (1985) 0.75
[Cyclophosphamide, adriamycin and platinum (CAP) in the preoperative neoadjuvant phase and the therapy phase]. Chir Ital (1986) 0.75
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. Methods Find Exp Clin Pharmacol (1989) 0.75
Reduction of MCa mammary carcinoma in mice fed with egg-white lysozyme. Pharmacol Res (1991) 0.75
[Chemical and pharmaceutical research on pyran derivatives. XI. Synthesis of 2-dialkylamino-4-oxo-10-methyl-4H-naphtho[2,3b]pyrans]. Farmaco Sci (1978) 0.75
[Presence of hyaluronic acid in subjects with keratoconus]. Arch Ital Anat Embriol (1987) 0.75
Zinc metabolism and immune function in healthy elderly people. Clin Nutr (1994) 0.75
[Salivary immunoglobulins G, A and M in liver cirrhosis]. Minerva Med (1981) 0.75
[1,5-Benzodiazepines. III. Synthesis of 2,4-bisdialkylamino-3H-1,5-benzodiazepines]. Farmaco Sci (1979) 0.75
A phase II study of mitoxantrone. Tumori (1988) 0.75
Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma. Anticancer Res (1989) 0.75
Monoclonal antibody defined T cell subsets in primary and secondary Sjögren's syndrome. Boll Ist Sieroter Milan (1986) 0.75
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. Pharmacol Res (1990) 0.75
Treatment of human strongyloidiasis with cambendazole, a new anthelminthic. Double-blind study. Mater Med Pol (1986) 0.75
[Chemical and pharmacological research on pyran derivatives. VII. Derivatives of naphto/1',2':5,6/pyran/2,3-c/pyrazole and of 12H-naphto/1',2':5,6/pyran/2,3-d/pyrimidine]. Farmaco Sci (1977) 0.75
B lymphocytes in newborns. Arch Immunol Ther Exp (Warsz) (1981) 0.75
[1,5-benzodiazepines. V. Synthesis of pyrazolo (3,4-b)(1,5)benzodiazepines and 5H-pyrimido(4,5-b)(1,5)benzodiazepines]. Farmaco Sci (1983) 0.75